These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 24709902)

  • 41. Breast cancer metastasis driven by ErbB2 and 14-3-3zeta: A division of labor.
    Wang Y
    Cell Adh Migr; 2010; 4(1):7-9. PubMed ID: 20009581
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.
    Nagy P; Jenei A; Damjanovich S; Jovin TM; Szölôsi J
    Pathol Oncol Res; 1999; 5(4):255-71. PubMed ID: 10607920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ganetespib targets multiple levels of the receptor tyrosine kinase signaling cascade and preferentially inhibits ErbB2-overexpressing breast cancer cells.
    Lee H; Saini N; Howard EW; Parris AB; Ma Z; Zhao Q; Zhao M; Liu B; Edgerton SM; Thor AD; Yang X
    Sci Rep; 2018 May; 8(1):6829. PubMed ID: 29717218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MMP-2 mediates ethanol-induced invasion of mammary epithelial cells over-expressing ErbB2.
    Ke Z; Lin H; Fan Z; Cai TQ; Kaplan RA; Ma C; Bower KA; Shi X; Luo J
    Int J Cancer; 2006 Jul; 119(1):8-16. PubMed ID: 16450376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brk is coamplified with ErbB2 to promote proliferation in breast cancer.
    Xiang B; Chatti K; Qiu H; Lakshmi B; Krasnitz A; Hicks J; Yu M; Miller WT; Muthuswamy SK
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12463-8. PubMed ID: 18719096
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ERBB2 up-regulates S100A4 and several other prometastatic genes in medulloblastoma.
    Hernan R; Fasheh R; Calabrese C; Frank AJ; Maclean KH; Allard D; Barraclough R; Gilbertson RJ
    Cancer Res; 2003 Jan; 63(1):140-8. PubMed ID: 12517790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anti-metastasis activity of black rice anthocyanins against breast cancer: analyses using an ErbB2 positive breast cancer cell line and tumoral xenograft model.
    Luo LP; Han B; Yu XP; Chen XY; Zhou J; Chen W; Zhu YF; Peng XL; Zou Q; Li SY
    Asian Pac J Cancer Prev; 2014; 15(15):6219-25. PubMed ID: 25124601
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
    Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J
    Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
    Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ERBB2 gene expression silencing involved in ovarian cancer cell migration and invasion through mediating MAPK1/MAPK3 signaling pathway.
    Yu TT; Wang CY; Tong R
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5267-5280. PubMed ID: 32495860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin.
    Yuste L; Montero JC; Esparís-Ogando A; Pandiella A
    Cancer Res; 2005 Aug; 65(15):6801-10. PubMed ID: 16061662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.
    Bisaro B; Sciortino M; Colombo S; Camacho Leal MP; Costamagna A; Castellano I; Montemurro F; Rossi V; Valabrega G; Turco E; Defilippi P; Cabodi S
    Oncotarget; 2016 Jan; 7(4):4442-53. PubMed ID: 26716506
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of multiple cancer-associated genes at the ERBB2 amplicon in breast cancer.
    Kauraniemi P; Kallioniemi A
    Endocr Relat Cancer; 2006 Mar; 13(1):39-49. PubMed ID: 16601278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ErbB2-mediated Src and signal transducer and activator of transcription 3 activation leads to transcriptional up-regulation of p21Cip1 and chemoresistance in breast cancer cells.
    Hawthorne VS; Huang WC; Neal CL; Tseng LM; Hung MC; Yu D
    Mol Cancer Res; 2009 Apr; 7(4):592-600. PubMed ID: 19372587
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ErbB2-dependent downregulation of a pro-apoptotic protein Perp is required for oncogenic transformation of breast epithelial cells.
    Khan IA; Yoo BH; Masson O; Baron S; Corkery D; Dellaire G; Attardi LD; Rosen KV
    Oncogene; 2016 Nov; 35(44):5759-5769. PubMed ID: 27109096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Rac-Pak signaling pathway is essential for ErbB2-mediated transformation of human breast epithelial cancer cells.
    Arias-Romero LE; Villamar-Cruz O; Pacheco A; Kosoff R; Huang M; Muthuswamy SK; Chernoff J
    Oncogene; 2010 Oct; 29(43):5839-49. PubMed ID: 20711231
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation.
    Holbro T; Beerli RR; Maurer F; Koziczak M; Barbas CF; Hynes NE
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8933-8. PubMed ID: 12853564
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ethanol enhances the interaction of breast cancer cells over-expressing ErbB2 with fibronectin.
    Xu M; Bower KA; Chen G; Shi X; Dong Z; Ke Z; Luo J
    Alcohol Clin Exp Res; 2010 May; 34(5):751-60. PubMed ID: 20201928
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expression.
    Stevenson LE; Frackelton AR
    Breast Cancer Res Treat; 1998 May; 49(2):119-28. PubMed ID: 9696394
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phosphoinositide 3-kinase targeting by the beta galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death.
    Wells V; Mallucci L
    Breast Cancer Res; 2009; 11(1):R2. PubMed ID: 19133120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.